4.“I'm healthy, I don't have pain”- health screening participation and its association with chronic pain in a low socioeconomic status Singaporean population.
Liang En WEE ; David SIN ; Wen Qi CHER ; Zong Chen LI ; Tammy TSANG ; Sabina SHIBLI ; Gerald KOH
The Korean Journal of Pain 2017;30(1):34-43
BACKGROUND: We sought to determine the association between chronic pain and participating in routine health screening in a low socioeconomic-status (SES) rental-flat community in Singapore. In Singapore, ≥ 85% own homes; public rental flats are reserved for those with low-income. METHODS: Chronic pain was defined as pain ≥ 3 months. From 2009−2014, residents aged 40−60 years in five public rental-flat enclaves were surveyed for chronic pain; participation in health screening was also measured. We compared them to residents staying in adjacent owner-occupied public housing. We also conducted a qualitative study to better understand the relationship between chronic pain and health screening participation amongst residents in these low-SES enclaves. RESULTS: In the rental-flat population, chronic pain was associated with higher participation in screening for diabetes (aOR = 2.11, CI = 1.36−3.27, P < 0.001), dyslipidemia (aOR = 2.06, CI = 1.25−3.39, P = 0.005), colorectal cancer (aOR = 2.28, CI = 1.18−4.40, P = 0.014), cervical cancer (aOR = 2.65, CI = 1.34−5.23, P = 0.005) and breast cancer (aOR = 3.52, CI = 1.94−6.41, P < 0.001); this association was not present in the owner-occupied population. Three main themes emerged from our qualitative analysis of the link between chronic pain and screening participation: pain as an association of “major illness”; screening as a search for answers to pain; and labelling pain as an end in itself. CONCLUSIONS: Chronic pain was associated with higher cardiovascular and cancer screening participation in the low-SES population. In low-SES populations with limited access to pain management services, chronic pain issues may surface during routine health screening.
Asian Continental Ancestry Group
;
Breast Neoplasms
;
Chronic Pain*
;
Colorectal Neoplasms
;
Dyslipidemias
;
Early Detection of Cancer
;
Humans
;
Mass Screening*
;
Pain Management
;
Public Housing
;
Singapore
;
Social Class*
;
Uterine Cervical Neoplasms
5.Antitumor effect of calcium phosphate cement incorporating doxorubicin microspheres.
Hui ZHANG ; Zhong-lin XUE ; An-min QI ; Sin LI ; Jian-dong YE
Journal of Southern Medical University 2010;30(2):278-283
OBJECTIVETo investigate the antitumor effect of calcium phosphate cement incorporated with doxorubicin microspheres.
METHODSThe absorbance at 490 nm of SaoS-2 cells cultured for 5 days in the media containing the extract of the cement incorporating doxorubicin microspheres was measured using Cell Counting Kit-8. SaoS-2 cells were adjusted to the density of 2x10(7) ml(-1) and injected into the left buttock of nude mouse in the volume of 0.2 ml. The cell suspension (0.1 ml) mixed with an equal volume of the cement extract were injected into the right buttock and on the back of the bilateral ears of nude mice. At 12 days after the cell injection, the tumor tissues were obtained and weighed to calculate the tumor inhibition rate, and the pathological samples were observed with HE staining.
RESULTSThe extract of the bone cement containing doxorubicin microspheres showed inhibitory effects on the tumor growth in a dose-dependent manner. The tumor inhibition rate reached 61.0% in high-dose group. Tumor necrosis was found in high dose group, but virtually absent in low-dose group.
CONCLUSIONSCPC containing doxorubicin PLGA microspheres can inhibit tumor cell growth both in vitro and in vivo.
Animals ; Antibiotics, Antineoplastic ; pharmacology ; Bone Cements ; pharmacology ; Bone Neoplasms ; drug therapy ; pathology ; Calcium Phosphates ; pharmacology ; Cell Line, Tumor ; Delayed-Action Preparations ; Doxorubicin ; pharmacology ; Female ; Male ; Mice ; Mice, Nude ; Microspheres ; Osteosarcoma ; drug therapy ; pathology
6.Tetanus in an injecting buprenorphine abuser.
Felicia S W TEO ; Li Yang HSU ; Khim Nian Sin Fai LAM ; A JOHAN
Annals of the Academy of Medicine, Singapore 2007;36(12):1021-1023
INTRODUCTIONInjecting drug abusers are vulnerable to many infectious complications. We describe a case of tetanus in a Singaporean who regularly abused buprenorphine.
CLINICAL PICTUREA 49-year-old male was hospitalised for progressive generalised spasms associated with dysarthria and opisthotonus. Tetanus was diagnosed clinically.
TREATMENTSupportive management was instituted in the intensive care unit (ICU). Toxicology samples tested positive for buprenorphine.
OUTCOMEHe recovered rapidly and was transferred out of the ICU after 8 days. Retrospective questioning confirmed parenteral abuse of buprenorphine.
CONCLUSIONThis case highlights an uncommon and potentially lethal complication of parenteral drug abuse.
Buprenorphine ; Disease Progression ; Dysarthria ; Humans ; Male ; Middle Aged ; Singapore ; Substance Abuse, Intravenous ; Substance-Related Disorders ; complications ; Tetanus ; diagnosis ; etiology ; therapy
7.Management of Percutaneous Endoscopic Gastrostomy Site Gastric Ulcer in a Patient with an Esophageal Stricture and Hiatus Hernia
Clement C H WU ; James W LI ; Keng Sin NG ; Daphne S ANG
Clinical Endoscopy 2018;51(1):99-102
Percutaneous endoscopic gastrostomy (PEG) is commonly performed for feeding difficulties, in patients suffering from complications of nasopharyngeal carcinoma and its treatment, namely radiotherapy and surgery. This case report describes the challenges in hemostasis and subsequent re-establishment of enteral access for feeding, in an elderly patient with a history of NPC, treated surgically, followed by radiotherapy, who presented with massive hematemesis following reinsertion of her PEG shortly after an accidental dislodgement. Her previous nasopharyngectomy, wide field radiation therapy, and radical neck dissection precluded nasogastric tube feeding, and the presence of a large hiatus hernia made reinsertion of a new PEG technically challenging. This case highlights the methods used to overcome the above challenges.
Aged
;
Enteral Nutrition
;
Esophageal Stenosis
;
Gastrostomy
;
Hematemesis
;
Hemostasis
;
Hernia, Hiatal
;
Humans
;
Intubation, Gastrointestinal
;
Neck Dissection
;
Radiotherapy
;
Stomach Ulcer
;
Ulcer
8.Dexamethasone-induced differentiation of pancreatic AR42J cell involves p21(waf1/cip1)and MAP kinase pathway.
Won Sik EUM ; Ming Zhen LI ; Gye Suk SIN ; Soo Young CHOI ; Jae Bong PARK ; Jae Yong LEE ; Hyeok Yil KWON
Experimental & Molecular Medicine 2003;35(5):379-384
Dexamethasone converts pluripotent pancreatic AR42J cells into exocrine cells expressing digestive enzymes. In order to address molecular mechanism of this differentiation, we have investigated the role of mitogen-activated protein (MAP) kinase pathway and gene expressions of p21(waf1/cip1)and nuclear oncogenes (c-fos and c-myc) during AR42J cell differentiation. Dexamethasone markedly increased the intracellular and secreted amylase contents as well as its mRNA level. However, cell growth and DNA content were significantly decreased. With these phenotypic changes, AR42J cells induced transient mRNA expression of p21(waf1/cip1)gene, which reached maximal level by 6 h and then declined gradually toward basal state. In contrast to p21(waf1/cip1), c-fos gene expression was transiently inhibited by 6 h and then recovered to basal level by 24 h. Increased c-myc expression detected after 3 h, peaked by 12 h, and remained elevated during the rest of observation. Dexamethasone inhibited epidermal growth factor-induced phosphorylation of extracellular signal regulated kinase. Inhibition of MAP kinase pathway by PD98059 resulted in further elevation of the dexamethasone-induced amylase mRNA and p21(waf1/cip1)gene expression. These results suggest that p21(waf1/cip1)and nuclear oncogenes are involved in dexamethasone-induced differentiation and inhibition of MAP kinase pathway accelerates the conversion of undifferentiated AR42J cells into amylase-secreting exocrine cells.
Amylases/genetics
;
Animals
;
Cell Differentiation/*drug effects
;
Cell Division/drug effects
;
Cell Line, Tumor
;
Cyclins/genetics/*metabolism
;
Dexamethasone/*pharmacology
;
Gene Expression Regulation/drug effects
;
Genes, fos/genetics
;
Genes, myc/genetics
;
MAP Kinase Signaling System/*drug effects
;
Mitogen-Activated Protein Kinases/*metabolism
;
Pancreas/cytology/*drug effects/enzymology/metabolism
;
RNA, Messenger/genetics/metabolism
;
Rats
;
Support, Non-U.S. Gov't
9.Changes in Transepidermal Water Loss and Skin Hydration according to Expression of Aquaporin-3 in Psoriasis.
Young LEE ; Young Jin JE ; Sang Sin LEE ; Zheng Jun LI ; Dae Kyoung CHOI ; Yoo Bin KWON ; Kyung Cheol SOHN ; Myung IM ; Young Joon SEO ; Jeung Hoon LEE
Annals of Dermatology 2012;24(2):168-174
BACKGROUND: Aquaporins (AQPs) are a family of water transporting proteins present in many mammalian epithelial and endothelial cell types. Among the AQPs, AQP3 is known to be a water/glycerol transporter expressed in human skin. OBJECTIVE: The relationship between the expression level of AQP3 and transpidermal water loss (TEWL) in the lesional and peri-lesional skin of psoriasis-affected patients, and skin hydration in the lesional and peri-lesional skin of psoriasis patients, was investigated. METHODS: The expression of AQP3 in psoriasis-affected and healthy control skin was determined using immunohistochemical and immunofluroscence staining. TEWL and skin hydration were measured using a Tewameter(R) TM210 (Courage & Khazaka, Cologne, Germany) and a Corneometer(R) CM 820 (Courage & Khazaka), respectively. RESULTS: AQP3 was mainly expressed in the plasma membrane of stratum corneum and the stratum spinosum in normal epidermis. Unlike the normal epidermis, AQP3 showed decreased expression in the lesional and peri-lesional epidermis of psoriasis. TEWL was increased, and skin hydration was decreased, in the lesional and peri-lesional skin of psoriasis patients, compared with the healthy control sample. CONCLUSION: Although various factors contribute to reduced skin hydration in the lesional and peri-lesional skin of psoriasis, AQP3 appears to be a key factor in the skin dehydration of psoriasis-affected skin.
Aquaporin 3
;
Aquaporins
;
Cell Membrane
;
Dehydration
;
Endothelial Cells
;
Epidermis
;
Humans
;
Proteins
;
Psoriasis
;
Skin
;
Water Loss, Insensible
10.Expression of Class I and Class II a/b Histone Deacetylase is Dysregulated in Hypertensive Animal Models.
Hae Jin KEE ; Gwi Ran KIM ; Ming Quan LIN ; Sin Young CHOI ; Yuhee RYU ; Li JIN ; Zhe Hao PIAO ; Myung Ho JEONG
Korean Circulation Journal 2017;47(3):392-400
BACKGROUND AND OBJECTIVES: Dysregulation of histone deacetylase expression and enzymatic activity is associated with a number of diseases. It has been reported that protein levels of histone deacetylase (HDAC)1 and HDAC5 increase during human pulmonary hypertension, and that the enzymatic activity of HDAC6 is induced in a chronic hypertensive animal model. This study investigated the protein expression profiles of class I and II a/b HDACs in three systemic hypertension models. SUBJECTS AND METHODS: We used three different hypertensive animal models: (i) Wistar-Kyoto rats (n=8) and spontaneously hypertensive rats (SHR; n=8), (ii) mice infused with saline or angiotensin II to induce hypertension, via osmotic mini-pump for 2 weeks, and (iii) mice that were allowed to drink L-N(G)-nitro-L-arginine methyl ester (L-NAME) to induce hypertension. RESULTS: SHR showed high systolic, diastolic, and mean blood pressures. Similar increases in systolic blood pressure were observed in angiotensin II or L-NAME-induced hypertensive mice. In SHR, class IIa HDAC (HDAC4, 5, and 7) and class IIb HDAC (HDAC6 and 10) protein expression were significantly increased. In addition, a HDAC3 protein expression was induced in SHR. However, in L-NAME mice, class IIa HDAC protein levels (HDAC4, 5, 7, and 9) were significantly reduced. HDAC8 protein levels were significantly reduced both in angiotensin II mice and in SHR. CONCLUSION: These results indicate that dysregulation of class I and class II HDAC protein is closely associated with chronic hypertension.
Angiotensin II
;
Animals*
;
Blood Pressure
;
Histone Deacetylases*
;
Histones*
;
Humans
;
Hypertension
;
Hypertension, Pulmonary
;
Mice
;
Models, Animal*
;
NG-Nitroarginine Methyl Ester
;
Rats
;
Rats, Inbred SHR